ACR updates guidelines for peri-TJA med use in rheumatic disease
Long-term risks examined for survivors of adolescent, young adult hematologic cancers
21 March 2022Nontoxic, variable-stiffness threads for dexterous cardiac catheters
21 March 2022ACR updates guidelines for peri-TJA med use in rheumatic disease
In a guideline summary issued by the American College of Rheumatology (ACR) and the American Association of Hip and Knee Surgeons (AAHKS), updated recommendations are presented for the use of medications among patients with rheumatic disease undergoing elective total hip arthroplasty (THA) and total knee arthroplasty (TKA). The complete guideline is scheduled to be published in the summer of 2022.
